e-ISSN 2329-0072

Logo

Medical
MSM  BR

AmJCaseRep

Get your full text copy in PDF

Pharmacotherapy of neoplasmatic pain

Aleksandra Ciałkowska-Rysz

Med Sci Tech 2006; 47(1): RP3-8

ID: 881484


Pain always accompanies neoplasmatic disease, especially in its finalstage.In about 90% of patients pain can be canceled using only pharmacotherapy. The treatment of neoplasmatic painis based on the recommendations of WHO. According with them in pain therapy drugs should be given individually, in regular intervals, and in most convenient way for the patient. It is also necessary to monitor the efficacy and safety (adverseevents) of therapy.In case of ‘piercing’ pains each patients should receive additional doses of analgetics. The choice of medicineis based on the “three degrees analgesic scale” First choice treatment: paracetamol and non steroidal anti-inflammatory drugs (NSAIDs) are described as no nopioidanalgesics. The second line drugs (tramadol, codeine, dihydrocodeine) are weekopioids.Strong opioids are on the third degree of analgesics scale, morphine, phentanyl, buprenorphine and metadon are representatives of this group in Poland. In necessary the adjuvant therapy could be added to each group of medicines. (Clin. Exp. Med. Lett. 2006; 47(1):3-8)

Keywords: cancer pain, WHO analgesic ladder, opioids

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree